z-logo
Premium
Are Clinical Therapeutic Protein‐Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction?
Author(s) -
Pang Yinuo,
Rosebraugh Matthew R.,
Freise Kevin J.,
Parikh Apurvasena,
Mohamed MohamedEslam F.
Publication year - 2018
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1290
Subject(s) - drug , proinflammatory cytokine , medicine , disease , pharmacology , drug interaction , cytokine , immunology , bioinformatics , inflammation , biology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom